Bronchodilator reversibility among patients with asthma presenting to tertiary care hospitals in Trivandrum, India

S. Nair, P. Arjun
{"title":"Bronchodilator reversibility among patients with asthma presenting to tertiary care hospitals in Trivandrum, India","authors":"S. Nair, P. Arjun","doi":"10.1183/13993003.congress-2019.pa715","DOIUrl":null,"url":null,"abstract":"Introduction: Demonstration of post-bronchodilator reversibility is considered as an important tool for the diagnosis of Asthma, however this is not demonstrable in all patients. Aims and Objectives: To determine the proportion of patients with Asthma presenting to tertiary care hospital in Trivandrum, South India who show post-bronchodilator reversibility on spirometry and to determine the factors associated with reversibility Methods: Consecutive patients with clinician diagnosed asthma (by a senior pulmonologist, based on GINA guidelines) underwent spirometry as part of their diagnostic work-up at the time of their presentation in two tertiary care hospitals. Pre- and post bronchodilator spirometry were done by an expert technician. Reversibility was defined as increase in FEV1 by 200ml and 12% Results: 200 consecutive patients with Asthma were recruited. Mean age of the patients was 41.5 years (SD - 18.2). 59.5% of the patients were femaies. The proportion of patients with reversibility was 47% (95%CI-40%,54%). The factors associated with reversibility were low age( 0.05). Conclusion: While developing local guidelines for diagnosis of Asthma, the fact that reversibility can be demonstrated only less than 50% of patients must be considered, otherwise a significant proportion of cases with Asthma may be missed or misdiagnosed as COPD.","PeriodicalId":432006,"journal":{"name":"General practice and primary care","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"General practice and primary care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2019.pa715","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Demonstration of post-bronchodilator reversibility is considered as an important tool for the diagnosis of Asthma, however this is not demonstrable in all patients. Aims and Objectives: To determine the proportion of patients with Asthma presenting to tertiary care hospital in Trivandrum, South India who show post-bronchodilator reversibility on spirometry and to determine the factors associated with reversibility Methods: Consecutive patients with clinician diagnosed asthma (by a senior pulmonologist, based on GINA guidelines) underwent spirometry as part of their diagnostic work-up at the time of their presentation in two tertiary care hospitals. Pre- and post bronchodilator spirometry were done by an expert technician. Reversibility was defined as increase in FEV1 by 200ml and 12% Results: 200 consecutive patients with Asthma were recruited. Mean age of the patients was 41.5 years (SD - 18.2). 59.5% of the patients were femaies. The proportion of patients with reversibility was 47% (95%CI-40%,54%). The factors associated with reversibility were low age( 0.05). Conclusion: While developing local guidelines for diagnosis of Asthma, the fact that reversibility can be demonstrated only less than 50% of patients must be considered, otherwise a significant proportion of cases with Asthma may be missed or misdiagnosed as COPD.
印度特里凡得琅三级医院哮喘患者的支气管扩张剂可逆性
证明支气管扩张剂后可逆性被认为是诊断哮喘的重要工具,但并非在所有患者中都能证明这一点。目的和目的:确定到印度南部特里vandrum三级医院就诊的支气管扩张剂后肺活量测定显示可逆性的哮喘患者的比例,并确定与可逆性相关的因素。方法:连续的临床医生诊断为哮喘的患者(由高级肺科医生根据GINA指南)在两家三级医院就诊时进行了肺活量测定,作为诊断检查的一部分。支气管扩张剂前后肺活量测定由专业技术人员完成。可逆性定义为FEV1增加200ml和12%。结果:连续招募200例哮喘患者。患者平均年龄41.5岁(SD - 18.2)。女性占59.5%。可逆性患者比例为47% (95%CI-40%,54%)。与可逆性相关的因素是低年龄(0.05)。结论:在制定当地哮喘诊断指南时,必须考虑到只有不到50%的患者可以证明可逆性,否则可能会有很大比例的哮喘病例被漏诊或误诊为COPD。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信